NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets protein-based biosurgery and passive immunotherapy products, announced today that Robert Taub, President and Chief Executive Officer, is scheduled to give a company presentation at the Acumen BioFin 4th Annual Global Healthcare Conference on Monday, May 14, 2007 at 9:45 a.m. local time (3:45 a.m. NY Time) at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
